The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Traditional and New Influenza Vaccines
Open accessAbstract
SUMMARY: The challenges in successful vaccination against influenza using conventional approaches lie in their variable efficacy in different age populations, the antigenic variability of the circulating virus, and the production and manufacturing limitations to ensure safe, timely, and adequate supply of vaccine. The conventional influenza vaccine platform is based on stimulating immunity against the major neutralizing antibody target, hemagglutinin (HA), by virus attenuation or inactivation. Improvements to this conventional system have focused primarily on improving production and immunogenicity. Cell culture, reverse genetics, and baculovirus expression technology allow for safe and scalable production, while adjuvants, dose variation, and alternate routes of delivery aim to improve vaccine immunogenicity. Fundamentally different approaches that are currently under development hope to signal new generations of influenza vaccines. Such approaches target nonvariable regions of antigenic proteins, with the idea of stimulating cross-protective antibodies and thus creating a “universal” influenza vaccine. While such approaches have obvious benefits, there are many hurdles yet to clear. Here, we discuss the process and challenges of the current influenza vaccine platform as well as new approaches that are being investigated based on the same antigenic target and newer technologies based on different antigenic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213 · cited 6×
“Given the poor performance of TIVs in the elderly, Fluzone HighDose, a new formulation of TIV that contains four times the standard dose of HA, was approved for use in the elderly in the United States in 2010.”
BackgroundInfluentialFiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 2,077
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,924
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789
1918 Influenza: the Mother of All Pandemics
Taubenberger, J. K., & Morens, D. M. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.050979 · Cited by 1,686
Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
Herfst, S., Schrauwen, E. J. A., Linster, M., Chutinimitkul, S., de Wit, E., Munster, V. J., Sorrell, E. M., Bestebroer, T. M., Burke, D. F., Smith, D. J., et al. (2012) · Science · doi:10.1126/science.1213362 · Cited by 1,665
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
1918 Influenza: the Mother of All Pandemics
Taubenberger, J. K., & Morens, D. M. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1209.05-0979 · Cited by 1,590
A DNA transfection system for generation of influenza A virus from eight plasmids
Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G., & Webster, R. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100133697 · Cited by 1,565
Fouchier, R. A. M., Munster, V., Wallensten, A., Bestebroer, T. M., Herfst, S., Smith, D., Rimmelzwaan, G. F., Olsen, B., & Osterhaus, A. D. M. E. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2814-2822.2005 · Cited by 1,563
Imai, M., Watanabe, T., Hatta, M., Das, S. C., Ozawa, M., Shinya, K., Zhong, G., Hanson, A., Katsura, H., Watanabe, S., et al. (2012) · Nature · doi:10.1038/nature10831 · Cited by 1,523
Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory
Shedlock, D. J., & Shen, H. (2003) · Science · doi:10.1126/science.1082305 · Cited by 1,460
Influenza virus receptors in the human airway
Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N., & Kawaoka, Y. (2006) · Nature · doi:10.1038/440435a · Cited by 1,398
Dawood, F. S., Iuliano, A. D., Reed, C., Meltzer, M. I., Shay, D. K., Cheng, P.-Y., Bandaranayake, D., Breiman, R. F., Brooks, W. A., Buchy, P., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70121-4 · Cited by 1,363
Generation of influenza A viruses entirely from cloned cDNAs
Neumann, G., Watanabe, T., Ito, H., Watanabe, S., Goto, H., Gao, P., Hughes, M., Perez, D. R., Donis, R., Hoffmann, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9345 · Cited by 1,278
Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help
Sun, J. C., & Bevan, M. J. (2003) · Science · doi:10.1126/science.1083317 · Cited by 1,213
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203 · cited 1×
“(189) binding to similar but distinct domains in the stalk region”
BackgroundTime Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies
Carrat, F., Vergu, E., Ferguson, N. M., Lemaitre, M., Cauchemez, S., Leach, S., & Valleron, A.-J. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm375 · Cited by 1,133
Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130
A distinct lineage of influenza A virus from bats
Tong, S., Li, Y., Rivailler, P., Conrardy, C., Castillo, D. A. A., Chen, L.-M., Recuenco, S., Ellison, J. A., Davis, C. T., York, I. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116200109 · Cited by 1,103
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
(2010) · New England Journal of Medicine · doi:10.1056/nejmra1000449 · Cited by 1,062
Nair, H., Brooks, W. A., Katz, M., Roca, A., Berkley, J. A., Madhi, S. A., Simmerman, J. M., Gordon, A., Sato, M., Howie, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61051-9 · Cited by 1,006
(2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03793.x · Cited by 957
IMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES
Yewdell, J. W., & Bennink, J. R. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.51 · Cited by 944
Influenza Virus Evolution, Host Adaptation, and Pandemic Formation
Taubenberger, J. K., & Kash, J. C. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.05.009 · Cited by 941
Cytotoxic T-Cell Immunity to Influenza
McMichael, A. J., Gotch, F. M., Noble, G. R., & Beare, P. A. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307073090103 · Cited by 927
Probable Person-to-Person Transmission of Avian Influenza A (H5N1)
Ungchusak, K., Auewarakul, P., Dowell, S. F., Kitphati, R., Auwanit, W., Puthavathana, P., Uiprasertkul, M., Boonnak, K., Pittayawonganon, C., Cox, N. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044021 · Cited by 869
Estimates of deaths associated with seasonal influenza --- United States, 1976-2007.
Thompson, M. G., Shay, D. K., Zhou, H., Bridges, C. B., Cheng, P. Y., Burns, E. M., Bresee, J., & Cox, N. J. (2010) · MMWR Morbidity and Mortality Weekly Report · Cited by 859
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 822
Wrammert, J., Koutsonanos, D., Li, G.-M., Edupuganti, S., Sui, J., Morrissey, M., McCausland, M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777
Throsby, M., van den Brink, E., Jongeneelen, M., Poon, L. L. M., Alard, P., Cornelissen, L., Bakker, A., Cox, F., van Deventer, E., Guan, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003942 · Cited by 737
H5N1 Virus Attachment to Lower Respiratory Tract
van Riel, D., Munster, V. J., de Wit, E., Rimmelzwaan, G. F., Fouchier, R. A. M., Osterhaus, A. D. M. E., & Kuiken, T. (2006) · Science · doi:10.1126/science.1125548 · Cited by 691
Influenza virus assembly and budding
Rossman, J. S., & Lamb, R. A. (2011) · Virology · doi:10.1016/j.virol.2010.12.003 · Cited by 641
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
Steel, J., Lowen, A. C., Wang, T. T., Yondola, M., Gao, Q., Haye, K., García-Sastre, A., & Palese, P. (2010) · mBio · doi:10.1128/mbio.00018-10 · Cited by 533
The annual production cycle for influenza vaccine
Gerdil, C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00071-9 · Cited by 529
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus
YAP, K. L., ADA, G. L., & MCKENZIE, I. F. C. (1978) · Nature · doi:10.1038/273238a0 · Cited by 520
Nohynek, H., Jokinen, J., Partinen, M., Vaarala, O., Kirjavainen, T., Sundman, J., Himanen, S.-L., Hublin, C., Julkunen, I., Olsén, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033536 · Cited by 498
CD8+ T cells clear influenza virus by perforin or Fas-dependent processes
Topham, D. J., Tripp, R. A., & Doherty, P. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5197 · Cited by 486
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Ekiert, D. C., Kashyap, A. K., Steel, J., Rubrum, A., Bhabha, G., Khayat, R., Lee, J. H., Dillon, M. A., O’Neil, R. E., Faynboym, A. M., et al. (2012) · Nature · doi:10.1038/nature11414 · Cited by 481
Self-citationPetsch, B., Schnee, M., Vogel, A. B., Lange, E., Hoffmann, B., Voss, D., Schlake, T., Thess, A., Kallen, K.-J., Stitz, L., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2436 · Cited by 464 · cited 1×
“Petsch and colleagues showed that a stabilized mRNA vaccine formulation, delivered intradermally, was immunogenic and protective in various animal models (157).”
BackgroundTrial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
Clark, T. W., Pareek, M., Hoschler, K., Dillon, H., Nicholson, K. G., Groth, N., & Stephenson, I. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907650 · Cited by 445
Corti, D., Suguitan, A. L., Pinna, D., Silacci, C., Fernandez-Rodriguez, B. M., Vanzetta, F., Santos, C., Luke, C. J., Torres-Velez, F. J., Temperton, N. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41902 · Cited by 437
Lee, L. Y.-H., Ha, D. L. A., Simmons, C., de Jong, M. D., Chau, N. V. V., Schumacher, R., Peng, Y. C., McMichael, A. J., Farrar, J. J., Smith, G. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32460 · Cited by 422
Dose Sparing with Intradermal Injection of Influenza Vaccine
Kenney, R. T., Frech, S. A., Muenz, L. R., Villar, C. P., & Glenn, G. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa043540 · Cited by 422
Estimates of deaths associated with seasonal influenza --- United States, 1976-2007.
(2010) · PubMed · Cited by 419
Bresson, J.-L., Perronne, C., Launay, O., Gerdil, C., Saville, M., Wood, J., Höschler, K., & Zambon, M. C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68656-x · Cited by 411
Jegerlehner, A., Schmitz, N., Storni, T., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5598 · Cited by 397
Falsey, A. R., Treanor, J. J., Tornieporth, N., Capellan, J., & Gorse, G. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599790 · Cited by 388
Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Berthoud, T. K., Hamill, M., Lillie, P. J., Hwenda, L., Collins, K. A., Ewer, K. J., Milicic, A., Poyntz, H. C., Lambe, T., Fletcher, H. A., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq015 · Cited by 384
Immune responses to influenza virus infection
Kreijtz, J. H. C. M., Fouchier, R. A. M., & Rimmelzwaan, G. F. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.022 · Cited by 336
El Bakkouri, K., Descamps, F., De Filette, M., Smet, A., Festjens, E., Birkett, A., Van Rooijen, N., Verbeek, S., Fiers, W., & Saelens, X. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0902147 · Cited by 335
Serum Antibody Responses after Intradermal Vaccination against Influenza
Belshe, R. B., Newman, F. K., Cannon, J., Duane, C., Treanor, J., Van Hoecke, C., Howe, B. J., & Dubin, G. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa043555 · Cited by 332
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach
Talon, J., Salvatore, M., O'Neill, R. E., Nakaya, Y., Zheng, H., Muster, T., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070525997 · Cited by 320
Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
Vesikari, T., Knuf, M., Wutzler, P., Karvonen, A., Kieninger-Baum, D., Schmitt, H.-J., Baehner, F., Borkowski, A., Tsai, T. F., & Clemens, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010331 · Cited by 317
Fan, J., Liang, X., Horton, M. S., Perry, H. C., Citron, M. P., Heidecker, G. J., Fu, T.-M., Joyce, J., Przysiecki, C. T., Keller, P. M., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.02.021 · Cited by 315
Prausnitz, M. R., Mikszta, J. A., Cormier, M., & Andrianov, A. K. (2009) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-92165-3_18 · Cited by 314
Evidence for host-cell selection of influenza virus antigenic variants
Schild, G. C., Oxford, J. S., de Jong, J. C., & Webster, R. G. (1983) · Nature · doi:10.1038/303706a0 · Cited by 314
Chen, B. J., Leser, G. P., Morita, E., & Lamb, R. A. (2007) · Journal of Virology · doi:10.1128/jvi.00361-07 · Cited by 305
Wang, T. T., Tan, G. S., Hai, R., Pica, N., Ngai, L., Ekiert, D. C., Wilson, I. A., García-Sastre, A., Moran, T. M., & Palese, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013387107 · Cited by 302
Turley, C. B., Rupp, R. E., Johnson, C., Taylor, D. N., Wolfson, J., Tussey, L., Kavita, U., Stanberry, L., & Shaw, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.041 · Cited by 294
Bright, R. A., Carter, D. M., Daniluk, S., Toapanta, F. R., Ahmad, A., Gavrilov, V., Massare, M., Pushko, P., Mytle, N., Rowe, T., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.106 · Cited by 288
Wang, T. T., Tan, G. S., Hai, R., Pica, N., Petersen, E., Moran, T. M., & Palese, P. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000796 · Cited by 278
Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines
Monto, A. S., Ohmit, S. E., Petrie, J. G., Johnson, E., Truscon, R., Teich, E., Rotthoff, J., Boulton, M., & Victor, J. C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808652 · Cited by 277
Adaptation and Growth Characteristics of Influenza Virus at 25° C
MAASSAB, H. F. (1967) · Nature · doi:10.1038/213612a0 · Cited by 274
Galli, G., Hancock, K., Hoschler, K., DeVos, J., Praus, M., Bardelli, M., Malzone, C., Castellino, F., Gentile, C., McNally, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903181106 · Cited by 263
Holland, D., Booy, R., Looze, F. D., Eizenberg, P., McDonald, J., Karrasch, J., McKeirnan, M., Salem, H., Mills, G., Reid, J., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590434 · Cited by 254 · cited 1×
“vaccines in terms of immunogenicity in the elderly ( 60 years old) (116, 117).”
BackgroundKashyap, A. K., Steel, J., Oner, A. F., Dillon, M. A., Swale, R. E., Wall, K. M., Perry, K. J., Faynboym, A., Ilhan, M., Horowitz, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801367105 · Cited by 252
PUSHKO, P., TUMPEY, T., BU, F., KNELL, J., ROBINSON, R., & SMITH, G. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.098 · Cited by 249
Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
Lillie, P. J., Berthoud, T. K., Powell, T. J., Lambe, T., Mullarkey, C., Spencer, A. J., Hamill, M., Peng, Y., Blais, M.-E., Duncan, C. J. A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis327 · Cited by 248
Reed, C., Meltzer, M. I., Finelli, L., & Fiore, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.098 · Cited by 228
Recombinant protein vaccines produced in insect cells
Cox, M. M. J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.016 · Cited by 223
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
Van Kampen, K. R., Shi, Z., Gao, P., Zhang, J., Foster, K. W., Chen, D.-T., Marks, D., Elmets, C. A., & Tang, D.-C. C. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.07.043 · Cited by 220
Chapter 14 Baculovirus–Insect Cell Expression Systems
Jarvis, D. L. (2009) · Methods in Enzymology · doi:10.1016/s0076-6879(09)63014-7 · Cited by 219
Bommakanti, G., Citron, M. P., Hepler, R. W., Callahan, C., Heidecker, G. J., Najar, T. A., Lu, X., Joyce, J. G., Shiver, J. W., Casimiro, D. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007465107 · Cited by 214
La Gruta, N. L., Turner, S. J., & Doherty, P. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5553 · Cited by 210
Pau, M. G., Ophorst, C., Koldijk, M. H., Schouten, G., Mehtali, M., & Uytdehaag, F. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00508-9 · Cited by 195
Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
Bernstein, D. I., Edwards, K. M., Dekker, C. L., Belshe, R., Talbot, H. K. B., Graham, I. L., Noah, D. L., He, F., & Hill, H. (2008) · The Journal of Infectious Diseases · doi:10.1086/527489 · Cited by 195
Banzhoff, A., Gasparini, R., Laghi-Pasini, F., Staniscia, T., Durando, P., Montomoli, E., Capecchi, P., di Giovanni, P., Sticchi, L., Gentile, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004384 · Cited by 194
The need for quadrivalent vaccine against seasonal influenza
Belshe, R. B. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.028 · Cited by 193
Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans
Assarsson, E., Bui, H.-H., Sidney, J., Zhang, Q., Glenn, J., Oseroff, C., Mbawuike, I. N., Alexander, J., Newman, M. J., Grey, H., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01563-08 · Cited by 193
Jelinek, I., Leonard, J. N., Price, G. E., Brown, K. N., Meyer-Manlapat, A., Goldsmith, P. K., Wang, Y., Venzon, D., Epstein, S. L., & Segal, D. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002845 · Cited by 190
Rhorer, J., Ambrose, C. S., Dickinson, S., Hamilton, H., Oleka, N. A., Malinoski, F. J., & Wittes, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.11.093 · Cited by 189
Hoelscher, M. A., Garg, S., Bangari, D. S., Belser, J. A., Lu, X., Stephenson, I., Bright, R. A., Katz, J. M., Mittal, S. K., & Sambhara, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68076-8 · Cited by 189
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
Ledgerwood, J. E., Wei, C.-J., Hu, Z., Gordon, I. J., Enama, M. E., Hendel, C. S., McTamney, P. M., Pearce, M. B., Yassine, H. M., Boyington, J. C., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70240-7 · Cited by 188
The cardiovascular manifestations of influenza: A systematic review
Estabragh, Z. R., & Mamas, M. A. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.274 · Cited by 187
Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus.
Air, G. M. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7639 · Cited by 184
Pellegrini, M., Nicolay, U., Lindert, K., Groth, N., & Della Cioppa, G. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.101 · Cited by 183
Control of Influenza and Poliomyelitis with Killed Virus Vaccines
Salk, J., & Salk, D. (1977) · Science · doi:10.1126/science.320661 · Cited by 183
Barr, I. G., McCauley, J., Cox, N., Daniels, R., Engelhardt, O. G., Fukuda, K., Grohmann, G., Hay, A., Kelso, A., Klimov, A., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.11.043 · Cited by 179
Self-citationIntradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study
Arnou, R., Icardi, G., De Decker, M., Ambrozaitis, A., Kazek, M.-P., Weber, F., & Van Damme, P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.033 · Cited by 171
Neumann, G., Fujii, K., Kino, Y., & Kawaoka, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505587102 · Cited by 170
Inflammasomes as mediators of immunity against influenza virus
Pang, I. K., & Iwasaki, A. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.11.004 · Cited by 170
Human memory CTL response specific for influenza A virus is broad and multispecific
Gianfrani, C., Oseroff, C., Sidney, J., Chesnut, R. W., & Sette, A. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00105-1 · Cited by 169
Taylor, D. N., Treanor, J. J., Strout, C., Johnson, C., Fitzgerald, T., Kavita, U., Ozer, K., Tussey, L., & Shaw, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.001 · Cited by 160
Immunologic recognition of influenza virus-infected cells
Braciale, T. J. (1977) · Cellular Immunology · doi:10.1016/0008-8749(77)90170-8 · Cited by 158
Treanor, J. J., Sahly, H. M. E., King, J. C., Graham, I. L., Izikson, R., Kohberger, R. C., PATRIARCA, P. A., & Cox, M. M. J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.128 · Cited by 158
The development of live attenuated cold-adapted influenza virus vaccine for humans
Maassab, H. F., & Bryant, M. L. (1999) · Reviews in Medical Virology · Cited by 152
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.
Reber, A. J., Chirkova, T., Kim, J. H., Cao, W., Biber, R., Shay, D. K., & Sambhara, S. R. (2012) · Europe PMC (PubMed Central) · Cited by 151
Song, J. Y., Cheong, H. J., Hwang, I. S., Choi, W. S., Jo, Y. M., Park, D. W., Cho, G. J., Hwang, T. G., & Kim, W. J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.067 · Cited by 147
Smith, L. R., Wloch, M. K., Ye, M., Reyes, L., Boutsaboualoy, S., Dunne, C. E., Chaplin, J. A., Rusalov, D., Rolland, A. P., Fisher, C. L., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.01.029 · Cited by 145
Beyond Empiricism: Informing Vaccine Development through Innate Immunity Research
Levitz, S. M., & Golenbock, D. T. (2012) · Cell · doi:10.1016/j.cell.2012.02.012 · Cited by 144
Targeting Skin Dendritic Cells to Improve Intradermal Vaccination
Romani, N., Flacher, V., Tripp, C. H., Sparber, F., Ebner, S., & Stoitzner, P. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2010_118 · Cited by 140
Jones, S. W., Evans, K., McElwaine-Johnn, H., Sharpe, M. E., OXFORD, J. S., Lambkin‐Williams, R., Mant, T., Nolan, A., Zambon, M. C. F. A., Ellis, J., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.02.061 · Cited by 140
A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
Cox, R. J., Madhun, A. S., Hauge, S., Sjursen, H., Major, D., Kühne, M., Höschler, K., Saville, M. K., Vogel, F. R., Barclay, W., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.116 · Cited by 140
Buonaguro, L., Tornesello, M. L., Tagliamonte, M., Gallo, R. C., Wang, L., Kamin‐Lewis, R., Abdelwahab, S. F., Lewis, G. K., & Buonaguro, F. M. (2006) · Journal of Virology · doi:10.1128/jvi.00050-06 · Cited by 137
López-Macías, C. I. R., Ferat-Osorio, E. A., Tenorio-Calvo, A. V., Isibasi, A., Talavera, J. O., Arteaga-Ruiz, O., Arriaga‐Pizano, L., Hickman, S. P., Allende, M. C., Lenhard, K., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.099 · Cited by 135
Ansaldi, F., Bacilieri, S., Durando, P., Sticchi, L., Valle, L., Montomoli, E., Icardi, G., Gasparini, R., & Crovari, P. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.019 · Cited by 134
National Seasonal Influenza Vaccination Survey in Europe, 2008
Mereckiene, J., Cotter, S. M., Nicoll, A., Lévy-Bruhl, D., Ferro, A. M., Tridente, G., Zanoni, G., Berra, P., Salmaso, S., O’Flanagan, D., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.43.19017-en · Cited by 134
Sambhara, S. R., Kurichh, A., Miranda, R., Tumpey, T. M., Rowe, T., Renshaw, M. A., Arpino, R., Tamane, A., Kandil, A. A., James, O., et al. (2001) · Cellular Immunology · doi:10.1006/cimm.2001.1835 · Cited by 134
Gasparini, R., Pozzi, T., Montomoli, E., Fragapane, E., Senatore, F., Minutello, M., & Podda, A. (2001) · European Journal of Epidemiology · doi:10.1023/a:1017919305501 · Cited by 129
Structural basis of influenza virus neutralization
Han, T. K., & Marasco, W. A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05829.x · Cited by 129
Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A Antibodies
Sui, J., Sheehan, J., Hwang, W. C., Bankston, L. A., Burchett, S. K., Huang, C.-Y., Liddington, R., Beigel, J. H., & Marasco, W. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir121 · Cited by 129
Greenberg, D. P., Robertson, C. A., Noss, M. J., Blatter, M. M., Biedenbender, R., & Decker, M. D. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.074 · Cited by 118
Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults
Karron, R. A., Talaat, K. R., Luke, C. J., Callahan, K. A., Thumar, B., DiLorenzo, S. C., McAuliffe, J. M., Schappell, E., Suguitan, A. L., Mills, K., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.099 · Cited by 118
Berglund, P., Fleeton, M. N., Smerdou, C., & Liljeström, P. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00224-2 · Cited by 118
Ohshima, N., Iba, Y., Kubota‐Koketsu, R., Asano, Y., Okuno, Y., & Kurosawa, Y. (2011) · Journal of Virology · doi:10.1128/jvi.05397-11 · Cited by 115
Origin and Evolution of Influenza Virus Hemagglutinin Genes
Suzuki, Y., & Nei, M. (2002) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a004105 · Cited by 114
Braciale, T. J. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.3.673 · Cited by 114
Summary of Clinical Trials of Influenza Virus Vaccines in Adults
Parkman, P. D., Hopps, H. E., Rastogi, S. C., & Meyer, H. M. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.supplement_3.s722 · Cited by 113
Kees, U. R., & Krammer, P. H. (1984) · The Journal of Experimental Medicine · doi:10.1084/jem.159.2.365 · Cited by 111
Ge, X., Tan, V., Bollyky, P. L., Standifer, N. E., James, E. A., & Kwok, W. W. (2010) · Journal of Virology · doi:10.1128/jvi.02226-09 · Cited by 101
Heightened neurologic complications in children with pandemic H1N1 influenza
Ekstrand, J. J., Herbener, A., Rawlings, J., Turney, B., Ampofo, K., Korgenski, E. K., & Bonkowsky, J. L. (2010) · Annals of Neurology · doi:10.1002/ana.22184 · Cited by 100
Cross‐priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon
Chen, W., Masterman, K., Basta, S., Haeryfar, S. M. M., Dimopoulos, N., Knowles, B. B., Bennink, J. R., & Yewdell, J. W. (2003) · European Journal of Immunology · doi:10.1002/eji.200324257 · Cited by 97
Pushko, P., Pearce, M. B., Ahmad, A., Tretyakova, I., Smith, G., Belser, J. A., & Tumpey, T. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.068 · Cited by 91
Chen, W., & McCluskey, J. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95006-4 · Cited by 89
Pleguezuelos, O., Robinson, S., Stoloff, G. A., & Caparrós‐Wanderley, W. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.089 · Cited by 85
Iob, A., Brianti, G., Zamparo, E., & Gallo, T. (2005) · Epidemiology and Infection · doi:10.1017/s0950268805003936 · Cited by 83
Durando, P., Iudici, R., Alicino, C., Alberti, M., de Florentiis, D., Ansaldi, F., & Icardi, G. (2011) · Human Vaccines · doi:10.4161/hv.7.0.14560 · Cited by 81
Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture
Szymczakiewicz‐Multanowska, A., Groth, N., Bugarini, R., Lattanzi, M., Casula, D., Hilbert, A. K., Tsai, T. F., & Podda, A. (2009) · The Journal of Infectious Diseases · doi:10.1086/605505 · Cited by 80
King, J. C., Cox, M. M. J., Reisinger, K. S., HEDRICK, J. A., Graham, I. L., & PATRIARCA, P. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.032 · Cited by 79
FRANCIS, T. (1941) · The Lancet · doi:10.1016/s0140-6736(00)72235-5 · Cited by 77
DNA Vaccination in the Skin Using Microneedles Improves Protection Against Influenza
Song, J.-M., Kim, Y., Eunju, O., Compans, R. W., Prausnitz, M. R., & Kang, S. (2012) · Molecular Therapy · doi:10.1038/mt.2012.69 · Cited by 76
López-Macías, C. I. R. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.18757 · Cited by 74
Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection
Hui, D. S. C. (2008) · Respirology · doi:10.1111/j.1440-1843.2008.01247.x · Cited by 71
Reisinger, K. S., Block, S. L., Izu, A., Groth, N., & Holmes, S. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/605506 · Cited by 70
Kammer, A. R., Amacker, M., Rasi, S., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.052 · Cited by 66
Community-acquired influenza C virus infection in children
Moriuchi, H., Katsushima, N., Nishimura, H., Nakamura, K., & Numazaki, Y. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80489-5 · Cited by 62
A systematic review of intradermal influenza vaccines
Young, F., & Marra, F. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.077 · Cited by 62
Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans
Ledgerwood, J. E., Hu, Z., Gordon, I. J., Yamshchikov, G. V., Enama, M. E., Plummer, S. H., Bailer, R. T., Pearce, M. B., Tumpey, T. M., Koup, R. A., et al. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05663-11 · Cited by 58
A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins
Brady, M. I., & Furminger, I. G. S. (1976) · Journal of Hygiene · doi:10.1017/s002217240002458x · Cited by 57
Baldo, V., Baldovin, T., Pellegrini, M., Angiolelli, G., Majori, S., Floreani, A., Busana, M. C., Bertoncello, C., & Trivello, R. (2010) · Journal of Immunology Research · doi:10.1155/2010/517198 · Cited by 55
Vesikari, T., Forstén, A., Herbinger, K., Cioppa, G. D., Beygo, J., Borkowski, A., Groth, N., Bennati, M., & von Sonnenburg, F. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.12.009 · Cited by 55
Ghendon, Y. Z., Polezhaev, F. I., Lisovskaya, K. V., Medvedeva, T. E., Alexandrova, G. I., & Klimov, A. I. (1984) · Infection and Immunity · doi:10.1128/iai.44.3.730-733.1984 · Cited by 55
Molecular Characterization ofIn VivoAdjuvant Activity in Ferrets Vaccinated against Influenza Virus
Yuan, F., Rowe, T., Leon, A. J., Banner, D., Danesh, A., Xu, L., Ran, L., Bosinger, S. E., Guan, Y., Chen, H., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02305-09 · Cited by 52
Camilloni, B., Neri, M., Lepri, E., & Iorio, A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.078 · Cited by 52
Cheong, H. J., Song, J. Y., Heo, J. Y., Noh, J. Y., Choi, W. S., Park, D. W., Wie, S., & Kim, W. J. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05111-11 · Cited by 52
Banzhoff, A., Haertel, S., & Praus, M. (2011) · Human Vaccines · doi:10.4161/hv.7.5.14821 · Cited by 50
Eliasson, D. G., Helgeby, A., Schön, K., Nygren, C., Bakkouri, K. E., Fiers, W. C., Saelens, X., Lövgren, K., Nyström, I., & Lycke, N. Y. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.03.090 · Cited by 47
Novel vaccines against influenza viruses
Kang, S. M., Song, J. M., & Compans, R. W. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.037 · Cited by 45
Groth, N., Montomoli, E., Gentile, C., Manini, I., Bugarini, R., & Podda, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.003 · Cited by 45
Kitchen, L. W., & Vaughn, D. W. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.030 · Cited by 42
Shen, X., Söderholm, J., Lin, F. W., Kobinger, G., Bello, A., Gregg, D. A., Broderick, K. E., & Sardesai, N. Y. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.02.071 · Cited by 42
Babon, J. A. B., Cruz, J., Ennis, F. A., Yin, L., & Terajima, M. (2012) · Journal of Virology · doi:10.1128/jvi.06325-11 · Cited by 41
Murphy, B. R., Park, E. J., Gottlieb, P., & Subbarao, K. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00031-5 · Cited by 38
[Vaccination against influenza].
Przesmycki, F., Walkowska, E., Dobrowolska, H., Zych, Z., Feltynowski, A., Przybyłkiewicz, Z., & Zanski, J. (1954) · PubMed · Cited by 38
Zhang, X., Kong, W., Ashraf, S., & Curtiss, R. (2009) · Journal of Virology · doi:10.1128/jvi.00781-09 · Cited by 34
Fragapane, E., Gasparini, R., Schioppa, F. S., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00461-09 · Cited by 34
Sahly, H. M. E., Davis, C. E. L. B., Kotloff, K. L., Meier, J. L., Winokur, P. L., Wald, A., Johnston, C., George, S. L., Brady, R. C., Lehmann, C. E., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir837 · Cited by 33
Cold-adapted influenza viruses for use as live vaccines for man.
Maassab, H. F., Ca, H., & Herlocher, M. L. (1990) · PubMed · Cited by 31
Prymula, R., Usluer, G., Altınel, S., Sichova, R., & Weber, F. (2012) · Advances in Therapy · doi:10.1007/s12325-011-0090-5 · Cited by 25
Dhont, P., Albert, A., Brenders, P., Podwapinska, A., Pollet, A., Scheveneels, D., Tihon, F., Verheyden, I., Victor, J., & Samson, S. (2012) · Advances in Therapy · doi:10.1007/s12325-012-0025-9 · Cited by 16
Overton, E. T. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir838 · Cited by 4
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
The evolution of seasonal influenza viruses
Petrova, V. N., & Russell, C. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.118 · Cited by 846
Drug resistance in influenza A virus: the epidemiology and management
Hussain, M., Galvin, H., Haw, T. Y., Nutsford, A., & Husain, M. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s105473 · Cited by 439
Next-generation influenza vaccines: opportunities and challenges
Wei, C.-J., Crank, M. C., Shiver, J., Graham, B. S., Mascola, J. R., & Nabel, G. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0056-x · Cited by 332
Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview
Mostafa, A., Abdelwhab, E. M., Mettenleiter, T. C., & Pleschka, S. (2018) · Viruses · doi:10.3390/v10090497 · Cited by 290
Metadata
- Authors
- Wong, S.-S., & Webby, R. J.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2013-07
- Volume
- 26
- Issue
- 3
- Pages
- 476-492
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2169259155
- Cited by
- 372
- References
- 166
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.